Koninklijke Philips (NYSE:PHG – Get Free Report) has earned a consensus recommendation of “Hold” from the five research firms that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company.
A number of equities analysts recently issued reports on the company. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th. StockNews.com downgraded Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Thursday, November 14th.
Check Out Our Latest Report on Koninklijke Philips
Koninklijke Philips Trading Up 0.9 %
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of PHG. Wilmington Savings Fund Society FSB acquired a new position in shares of Koninklijke Philips in the third quarter worth $54,000. Sanctuary Advisors LLC grew its position in Koninklijke Philips by 17.5% in the third quarter. Sanctuary Advisors LLC now owns 58,435 shares of the technology company’s stock worth $1,912,000 after acquiring an additional 8,721 shares in the last quarter. XTX Topco Ltd increased its stake in shares of Koninklijke Philips by 73.0% during the 3rd quarter. XTX Topco Ltd now owns 30,726 shares of the technology company’s stock worth $1,005,000 after purchasing an additional 12,969 shares during the last quarter. EP Wealth Advisors LLC bought a new position in shares of Koninklijke Philips during the 3rd quarter valued at $205,000. Finally, Jane Street Group LLC lifted its stake in shares of Koninklijke Philips by 787.9% in the 3rd quarter. Jane Street Group LLC now owns 128,686 shares of the technology company’s stock valued at $4,211,000 after purchasing an additional 114,193 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- Bank Stocks – Best Bank Stocks to Invest In
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Using the MarketBeat Stock Split Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to invest in marijuana stocks in 7 stepsĀ
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.